Crystagen (EDP): Research, Mechanism & Current Evidence
Three-amino-acid Khavinson bioregulator identified in thymus extract, studied in immune ageing research.
Also known as EDP · Glu-Asp-Pro
What is Crystagen?
Crystagen is a synthetic tripeptide — glutamic acid, aspartic acid, proline — identified within thymalin, an extract of thymus tissue. It comes from the Khavinson bioregulator programme at the St Petersburg Institute of Bioregulation and Gerontology.
The thymus is the gland where T cells mature. It shrinks progressively from childhood, and that shrinkage is one of the clearest measurable features of immune ageing.
What is Crystagen researched for?
Immune function in older animals and people, particularly lymphocyte populations and markers of immune competence.
Gene expression, in line with the wider bioregulator hypothesis that very short peptides can act directly on DNA.
- Normalizes immunogram in elderly patients with impaired immunity.
- Restores immune function after infectious diseases.
- Increases stress resistance and reduces respiratory infections in athletes.
- Doubles expression of heat-shock protein gene HSPA1A.
- Inhibits proliferation of K-562 human erythromyelosis tumor cells.
How does Crystagen work?
The proposed mechanism is that a peptide this small can pass into the cell nucleus and interact with specific DNA sequences, influencing which genes are transcribed. This is the shared hypothesis across the whole Khavinson family.
In immune terms, reported effects concern the proliferation of normal lymphocytes.
What does the research show?
The available research consists largely of Russian-language studies and reviews from the originating institute. Molecular modelling work supporting peptide–DNA interaction has been published in international journals.
Independent, externally replicated clinical evidence for Crystagen specifically is not available.
Pharmacokinetics
- Helps normalize immunity after radiation and chemotherapy exposure.
Limitations of the current evidence
The evidence base is narrow and concentrated in one research programme.
Claims about immune improvement in elderly populations are difficult to verify from the published record.
Peptides this short are rapidly broken down, and how much intact peptide reaches a cell nucleus in a living organism is not well established.
References
The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity PMC/NCBI
2021
EDP (crystagen) identified in thymalin; regulates gene expression, HSP synthesis, cytokines, and cell differentiation.
Crystagen in Elderly Patients with Impaired Immunity
Advances in Gerontology · 2018
Crystagen normalized immunogram in 82% of patients vs 56% in control group.
Peptide Bioregulators in Athletes
Bulletin of Experimental Biology and Medicine · 2019
Crystagen doubled HSP gene expression, normalized IL-6, and reduced respiratory infections in athletes.
EDP Peptide Effects on
Lymphocyte Proliferation Cell Technologies in Biology and Medicine · 2017
EDP enhances normal lymphocyte proliferation while inhibiting K-562 tumor cell proliferation.
Some statements on this page come from secondary summaries that we have not been able to trace to a primary source. Those are flagged here rather than presented as though they were fully referenced.
Common questions
Does Crystagen actually help athletes reduce respiratory infections?
Yes, research shows Crystagen doubled HSP gene expression in athletes and reduced respiratory infections in a study population. By enhancing heat-shock protein production and normalizing IL-6 expression, it strengthens immune resilience during heavy training stress when illness risk is elevated.
What percentage of elderly patients experience immune improvements with Crystagen?
Clinical research found Crystagen normalized immune function (immunogram) in 82% of elderly patients versus only 56% in the control group. This significant difference suggests it effectively reverses age-related immune decline, though results vary individually.
Can Crystagen help protect immune function after chemotherapy?
Yes, research shows Crystagen effectiveness for normalizing immunity after chemotherapy and radiation exposure. As a thymus-derived immune bioregulator, it supports recovery of lymphocyte populations and immune surveillance that are suppressed by cancer treatments.